Pause med trombocytaggregationshaemmere hos kirurgiske patienter med kardiel stent

Mathias Johansen, Arash Afshari, Billy Kristensen

2 Citationer (Scopus)


Dual antiplatelet therapy with aspirin and clopidogrel is increasingly used for secondary prevention of cardiovascular events in patients with percutaneous coronary intervention. Anesthesiologists and surgeons are faced with the challenge of managing these patients prior to a surgical procedure. Premature discontinuation of antiplatelet therapy constitutes a substantial risk of stent thrombosis, myocardial infarction and death. Continuing therapy increases the risk of bleeding. We provide the latest evidence on this topic for patients awaiting non-cardiac surgery.
Bidragets oversatte titel[Discontinuation of treatment with platelet aggregation inhibitors in surgical patients with cardiac stents]
TidsskriftUgeskrift for Laeger
Udgave nummer11
Sider (fra-til)852-7
Antal sider6
StatusUdgivet - 15 mar. 2010


Dyk ned i forskningsemnerne om 'Pause med trombocytaggregationshaemmere hos kirurgiske patienter med kardiel stent'. Sammen danner de et unikt fingeraftryk.